SHC3

From Wikipedia, the free encyclopedia


SHC (Src homology 2 domain containing) transforming protein 3
Identifiers
Symbol(s) SHC3; N-Shc; NSHC; SHCC
External IDs OMIM: 605263 MGI106179 HomoloGene7536
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 53358 20418
Ensembl ENSG00000148082 ENSMUSG00000021448
Uniprot Q92529 Q3ZAX2
Refseq NM_016848 (mRNA)
NP_058544 (protein)
NM_009167 (mRNA)
NP_033193 (protein)
Location Chr 9: 90.82 - 90.98 Mb Chr 13: 51.44 - 51.58 Mb
Pubmed search [1] [2]

SHC (Src homology 2 domain containing) transforming protein 3, also known as SHC3, is a human gene.[1]


[edit] References

[edit] Further reading

  • O'Bryan JP, Songyang Z, Cantley L, et al. (1996). "A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.". Proc. Natl. Acad. Sci. U.S.A. 93 (7): 2729–34. PMID 8610109. 
  • Pelicci G, Dente L, De Giuseppe A, et al. (1996). "A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.". Oncogene 13 (3): 633–41. PMID 8760305. 
  • Nakamura T, Sanokawa R, Sasaki Y, et al. (1996). "N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.". Oncogene 13 (6): 1111–21. PMID 8808684. 
  • Menegon A, Leoni C, Benfenati F, Valtorta F (1997). "Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum.". Biochem. Biophys. Res. Commun. 238 (3): 800–5. doi:10.1006/bbrc.1997.7393. PMID 9325171. 
  • Wang JF, Ganju RK, Liu ZY, et al. (1997). "Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor.". Blood 90 (9): 3507–15. PMID 9345034. 
  • Nakamura T, Muraoka S, Sanokawa R, Mori N (1998). "N-Shc and Sck, two neuronally expressed Shc adapter homologs. Their differential regional expression in the brain and roles in neurotrophin and Src signaling.". J. Biol. Chem. 273 (12): 6960–7. PMID 9507002. 
  • Cook KK, Fadool DA (2002). "Two adaptor proteins differentially modulate the phosphorylation and biophysics of Kv1.3 ion channel by SRC kinase.". J. Biol. Chem. 277 (15): 13268–80. doi:10.1074/jbc.M108898200. PMID 11812778. 
  • Tarr PE, Roncarati R, Pelicci G, et al. (2002). "Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc.". J. Biol. Chem. 277 (19): 16798–804. doi:10.1074/jbc.M110286200. PMID 11877420. 
  • Liu HY, Meakin SO (2002). "ShcB and ShcC activation by the Trk family of receptor tyrosine kinases.". J. Biol. Chem. 277 (29): 26046–56. doi:10.1074/jbc.M111659200. PMID 12006576. 
  • Miyake I, Hakomori Y, Shinohara A, et al. (2002). "Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines.". Oncogene 21 (38): 5823–34. doi:10.1038/sj.onc.1205735. PMID 12185581. 
  • Pelicci G, Troglio F, Bodini A, et al. (2002). "The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.". Mol. Cell. Biol. 22 (20): 7351–63. PMID 12242309. 
  • Nakamura T, Komiya M, Sone K, et al. (2003). "Grit, a GTPase-activating protein for the Rho family, regulates neurite extension through association with the TrkA receptor and N-Shc and CrkL/Crk adapter molecules.". Mol. Cell. Biol. 22 (24): 8721–34. PMID 12446789. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Miyake I, Hakomori Y, Misu Y, et al. (2005). "Domain-specific function of ShcC docking protein in neuroblastoma cells.". Oncogene 24 (19): 3206–15. doi:10.1038/sj.onc.1208523. PMID 15735675. 
  • Magrassi L, Conti L, Lanterna A, et al. (2005). "Shc3 affects human high-grade astrocytomas survival.". Oncogene 24 (33): 5198–206. doi:10.1038/sj.onc.1208708. PMID 15870690. 
  • De Falco V, Guarino V, Malorni L, et al. (2005). "RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors.". Oncogene 24 (41): 6303–13. doi:10.1038/sj.onc.1208776. PMID 15940252. 
  • Toschi E, Bacigalupo I, Strippoli R, et al. (2006). "HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.". Mol. Biol. Cell 17 (4): 1985–94. doi:10.1091/mbc.E05-08-0717. PMID 16436505. 
  • Li MD, Sun D, Lou XY, et al. (2007). "Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence.". Mol. Psychiatry 12 (5): 462–73. doi:10.1038/sj.mp.4001933. PMID 17179996.